Bortezomib in patients with relapsed or refractory mantle cell lymphoma: updated time-to-event analyses of the multicenter phase 2 PINNACLE study
Titel:
Bortezomib in patients with relapsed or refractory mantle cell lymphoma: updated time-to-event analyses of the multicenter phase 2 PINNACLE study
Auteur:
Goy, A. Bernstein, S.H. Kahl, B.S. Djulbegovic, B. Robertson, M.J. de Vos, S. Epner, E. Krishnan, A. Leonard, J.P. Lonial, S. Nasta, S. O'Connor, O.A. Shi, H. Boral, A.L. Fisher, R.I.